Ryan J Rebernick

6PUBLICATIONS
71CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunityGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 30, 2026
Genomic Determinants of Lethality and Therapeutic Vulnerability in Castration-Resistant Prostate Cancer.

|Oct 07, 2025
Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer.

Nofar Gumpert, Shira Sagie, Claudia Arnedo-Pac

|Aug 18, 2025
Divergent Clonal Evolution and Early Dissemination Promote Genetic Heterogeneity of Metastases in Castration-Resistant Prostate Cancer.

Noshad Hosseini, Rahul Mannan, Ryan J Rebernick

|Jun 26, 2025
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity.

Sanjana Eyunni, Rahul Mannan, Yuping Zhang

|Apr 22, 2024
Fmo5 plays a sex-specific role in goblet cell maturation and mucus barrier formation.

Megan L Schaller, Madeline M Sykes, Joy Mecano

|Jan 10, 2024
Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank.

Antonino Oliveri, Ryan J Rebernick, Annapurna Kuppa

Pageof 1

Frequent Collaborators

3 joint publications

Arul M Chinnaiyan

2 joint publications

Rui Wang

2 joint publications

Marcin P Cieslik

2 joint publications

Rohit Mehra